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Background: Although most countries in southern Africa have cervical cancer screening programs, these programs generally
fail to reach a significant majority of women because they are often implemented as pilot or research projects, and this limits
their scope and ability to scale up screening. Some countries have planned larger-scale programs, but these have either never
been implemented or have not been successfully scaled up. Most of the global burden of cervical cancer is experienced in countries
with limited resources, and mortality from cervical cancer is the most common cause of cancer-related deaths among women in
Sub-Saharan Africa.
Objective: The purpose of this study is to learn about preferences for cervical cancer screening in Zambia, to identify barriers
and facilitators for screening uptake, and to evaluate willingness to pay for screening services to support the scaling up of cervical
cancer screening programs.
Methods: We will conduct a discrete choice experiment by interviewing women and men and asking them to choose among
constructed scenarios with varying combinations of attributes relevant to cervical cancer screening. To inform the discrete choice
experiment, we will conduct focus groups and interviews about general knowledge and attitudes about cervical screening,
perception about the availability of screening, stigma associated with cancer and HIV, and payment for health care services. For
the discrete choice experiment, we will have a maximum design of 120 choice sets divided into 15 sets of 8 tasks each with a
sample size of 320-400 respondents. We will use a hierarchical Bayesian estimation procedure to assess attributes at the following
two levels: group and individual levels.
Results: The model will generate preferences for attributes to assess the most important features and allow for the assessment
of differences among cohorts. We will conduct policy simulations reflecting potential changes in the attributes of the screening
facilities and calculate the projected changes in preference for choosing to undergo cervical cancer screening. The findings from
the discrete choice experiment will be supplemented with interviews, focus groups, and patient surveys to ensure a comprehensive
and context-based interpretation of the results.
Conclusions: Because willingness to pay for cervical cancer screening has not been previously assessed, this will be a unique
and important contribution to the literature. This study will take into account the high HIV prevalence in Sub-Saharan Africa and
prevailing gender attitudes to identify an optimal package of interventions to reduce cervical cancer incidence. This simulation
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of women’s decisions (and men’s support) to undergo screening will lay the foundation for understanding the stated preferences
and willingness to pay to help design future screening programs.
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Introduction
Around the world, a woman dies of cervical cancer about every
2 minutes [1], with 528,000 new cases and 266,000 deaths in
2012. Cervical cancer affects women during their most
productive years because the majority are diagnosed under the
age of 50; therefore, cervical cancer adversely affects not only
women but also their families [2]. A large proportion of the
global burden is experienced in countries with limited resources,
and mortality from cervical cancer is the most common cause
of cancer-related deaths among women in Sub-Saharan Africa
[3,4]. The high prevalence of HIV in Sub-Saharan Africa, the
focal point of the HIV/AIDS epidemic, makes the cervical
cancer burden even more acute in these countries because
women with HIV have a much higher incidence rate of cervical
cancer than uninfected women [5]. Fortunately, given the
advances in HIV/AIDS treatment in Sub-Saharan Africa, women
are living longer with HIV, but unfortunately, they are dying
from cervical cancer due to the scarcity of large-scale
implementation of screening programs.
Cervical cancer is preventable, and early diagnosis is possible
using low-cost technologies [6]. The World Health Organization
guidelines recommend several screening approaches, including
tests for human papillomavirus (HPV) and cytology (Pap test)
and visual inspection with acetic acid (VIA) [7]. The
screen-and-treat approach using VIA or low-cost rapid HPV
test is the favored approach in the limited resource setting
because it minimizes loss to follow-up [8]. Therefore, the
knowledge and technology base exists to prevent and screen
for cervical cancer in low-resource settings and, as in other
settings, large-scale sustainable screening programs can be
implemented [9-11].
Although most countries in southern Africa have a cervical
cancer screening program that is either administered by the
government or nongovernmental organizations, these programs
generally fail to reach a significant majority of women [12].
This is largely because most screening activities in southern
Africa are part of pilot or research projects, which limits their
scope and ability to scale up screening. Some countries have
planned larger-scale programs, but these have either never been
implemented or have not been successfully scaled up. For
example, Malawi attempted a nationwide cytology-based
cervical cancer screening program, but it quickly deteriorated
owing to lack of resources, trained professionals, and
infrastructure [13].
Therefore, there is an urgent need to implement low-cost
approaches already available for the prevention and early
detection of cervical cancer in Sub-Saharan Africa. However,
to date, no study has systematically evaluated preferences for
prevention and screening, and this information is required to
design and implement programs that will result in optimal
uptake. Additionally, the financing of prevention and screening
services is a significant barrier for scale-up.
Although discrete choice experiments (DCEs) have been
performed in the context of maternal and child health, health
infrastructure, and workforce development in Africa [14-16],
no study has used validated quantitative methods to evaluate
the willingness to pay for cervical cancer screening in Africa.
Fee contributions based on an individual’s ability to pay, with
safeguards for ensuring free access for the disadvantaged
population, can provide a continuous, even if small, stream of
revenue to allow for the sustainability of program operations.
In this study, we will use DCE to elicit preferences for cervical
cancer screening to identify barriers and facilitators for screening
uptake and evaluate the willingness to pay for screening
services, which can inform innovative financing arrangements
to ensure sustainability. This study will be conducted in Zambia,
one of the countries with the highest burden of cervical cancer
in Sub-Saharan Africa.
Methods
Framework for Designing and Conducting the Discrete
Choice Experiments
In this study, women and men or partners of eligible women
will be asked to choose among constructed scenarios with
varying combinations of key attributes relevant to cervical
cancer screening (for example, type of provider, cost, and
distance to facility); choosing to have no screening will also be
an option. The DCE approach is preferred over asking women
and men about their willingness to pay directly in surveys or
interviews [17-19]. DCE allows participants to choose among
scenario combinations, an approach which provides them with
a more natural consumer choice experience. Figure 1 provides
an overview of the mixed-methods approach for implementing
DCE. We will begin by identifying initial concepts and
attributing levels for DCE based on feedback from experts and
a review of the literature related to cervical cancer screening
barriers and facilitators. Next, we will conduct a series of focus
groups and interviews with stakeholders in Zambia to finalize
the attributes and levels.
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Figure 1. Mixed-methods framework for the discrete choice experiment.
Focus Groups and In-Depth Interviews
We will conduct two sets of focus groups with women and
interviews with a range of stakeholders including women and
men who are between the ages of 25 and 49 years. We plan to
interview at least 8 individuals in each of the following groups:
women who are HIV-negative, those who are HIV-positive,
those who have been diagnosed with precancerous lesions, and
those treated for cancer.
We will also interview men in both urban and rural locations.
The focus groups and interviews will not address personal issues
but will be directed at understanding general knowledge and
attitudes about cervical screening, perception about the
availability of screening, stigma associated with cancer and
HIV, and payment for health care services. Written consent will
be obtained from all participants, and the consent form will be
translated into the local languages of Bemba, Nyanja, and
Tonga. We will also interview providers to gain knowledge
about the delivery of health care services, the use of cervical
cancer screenings, and facilitators and barriers related to cervical
cancer screening, diagnosis, and treatment. The key objective
of these discussions is to gain insight to finalize the attributes
and corresponding levels for DCE.
We will use a structured data collection template for
standardization and coding to facilitate analysis. We will
combine the qualitative information from all stakeholders to
assess convergence around common themes and identify
potential differences in viewpoints expressed by participants
on specific topics. The prespecified coding scheme (refined as
needed) will be used to perform a comparative assessment of
barriers and facilitators, program attributes, and financing
options. To assist in interpreting the findings, we will visually
display the data in tabular and graphical formats.
Discrete Choice Experiments Graphics, Choice Set
Selection, and Supplementary Survey
To permit use in a low-literacy environment, the attributes and
levels will be converted into graphics (see example of the
attributes and levels and the graphics provided in Table 1 and
Figure 2). Our DCE selection (Table 1) will generate 200
possible scenarios (52×23), which are too many for any single
respondent to assess. To select a fractional set of scenarios, we
will employ a randomized design process that ensures that
respondents see well-balanced and near-orthogonal fractions of
the full-choice design (8 choice decisions per respondent). We
will have no more than 128 profiles that will need to be tested
after developing the fractional set of scenarios. Wong et al
reported that even 729 possible profiles can be reduced to 128
profiles with a fractional factorial design [20]. In addition to
the choice tasks, we will administer a supplemental survey to
obtain demographics, socioeconomic status, reproductive history
(women only), cervical cancer screening knowledge and use
(women only), HIV status, access to care, attitudes toward using
formal medical care (compared with traditional medicine), and
stigma associated with HIV and cancer diagnosis.
Cohort Selection and Sample Size
A key design consideration for DCE is to allow for both
group-level and individual-level differences. The key groups
of interest are HIV-positive women, HIV-negative women,
women with unknown HIV status, and men (male partners). In
addition, it is important to distinguish between urban and rural
cohorts because they can differ in terms of participant attitudes,
cultural sensitivities, and health care infrastructure. Finally, to
also capture health-seeking behavior and potential underlying
differences between those who attend health clinics and those
who do not (owing to stigma, religion, traditional beliefs, cost,
and other reasons) [21], we also will draw specific cohorts from
health clinics and another set of cohorts from the wider
community. We describe the 7 cohorts targeted for DCE in
Textbox 1.
Sample size calculation for DCE studies in health care is an
evolving field. Johnson et al simulated sample sizes to estimate
precision that could be obtained for DCE studies [22]. They
found that precision increases rapidly at lower sample sizes
(less than 150 observations) and then flattens out at around 300
observations. Based on this, the rule of thumb for DCEs is that
generally 300-400 cases per group are adequate. Hall et al and
Lancsar and Louviere have indicated that about 20-25
respondents per choice set can provide precise parameter
estimates [23,24]. Our proposed study, with a maximum design
of 120 choice sets that will be divided into 15 sets of 8 tasks
each, can achieve this with a sample size of 320 to 400. Another
approach recommended by Johnson and Orme [25] suggests
that the sample size required for the main effects depends on
the number of choice tasks (t), the number of alternatives (a),
and the number of analysis cells (c) according to the following
equation: N>500c/(t×a). When considering the main effects, c
is equal to the largest number of levels for any of the attributes.
For our proposed model, the values are t=8, a=2 (without option
to select neither choice), and c=5 (main effects) or c=10 (based
on planned interaction between 5-level and 2-level attributes);
therefore, for the main effects, N can be estimated as
(500×5)/(8×2)=156.25 observations and for effects with
interactions, N can be estimated as (500×10)/(8×2)=312.50
observations.
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Table 1. Attributes and levels for the discrete choice experiment.
LevelAttribute
1, 1½, 2, 2½, 3Distance (hours by foot)
Free; not freeTransport
Middle-aged nurse; young nurseProvider
About half a day; full dayWait time
0, 25, 50, 75, 100Cost (in Zambian kwacha)
Figure 2. Discrete choice experiment: example graphics.
Textbox 1. Study cohorts for the discrete choice experiment. For each of the 7 groups, 400 individuals were selected. A previously conducted pilot test
included 15 women and 15 men.
1. Health clinic cohort
• HIV-positive women
• HIV-negative and unknown women






3. Justification for cohort selection
• Health clinic: To systematically identify HIV-positive women; women who attend clinics may also differ from the general population (owing
to stigma, traditional beliefs, cost, etc).
• Community: To understand screening preferences from cohorts that are most likely to reflect the general population.
In all the approaches identified above, a sample size of 400 per
group will be adequate to perform DCE to obtain preferences
and willingness to pay estimates for each of the 7 targeted
cohorts. Therefore, we will include a total sample of 2800
individuals.
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Identifying Discrete Choice Experiments Participants
Two health clinics that treat middle- and low-income individuals
in the Lusaka area will be randomly selected for the study; the
government operates multiple community-based clinics that
offer a similar set of services to our target cohort and, therefore,
we will be able to select a representative group of participants.
The study interviewers (recruited based on experience
performing similar studies) will visit the health centers to recruit
participants on a continuous basis by inviting eligible women
and men to complete the survey. Written consent will be
obtained, and the survey will be conducted in an allocated room
at the health center. For the community cohorts, we will identify
respondents in Lusaka (urban) and appropriate rural or semirural
setting. The interviews will take place at the residence of the
participant or at a nearby community center.
Discrete Choice Experiments Data Collection Process
We will train a team of 4 interviewers (fluent in English and
one of the other local languages) and a supervisor, who will be
responsible for the data collection. The graphics and software
created by RTI International (Research Triangle Park, North
Carolina, USA) will be loaded onto tablets to allow easy
manipulation and viewing by the respondent. The supplemental
survey and data collection pertaining to the DCE choices will
be entered directly into the tablet by the interviewer with quality
control features to ensure accuracy of data input formats (dates,
ages, and completeness of responses to questions). We will
pilot-test the data collection process with 30 women and men
(15 each) selected to reflect the targeted cohorts from Lusaka
and rural districts. We will introduce all respondents to the
graphics by presenting each illustration separately and
explaining the attribute and level in detail. Each participant will
become acquainted with the DCE approach through three
warm-up example choice decisions prior to the presentation of
the selected tradeoffs for that participant. After presenting the
DCE choices, the interviewer will verbally pose the survey
questions and record answers in the preformatted data collection
tool (approximately 45 minutes will be required for the
interviews). Respondents will be interviewed by one of the 4
trained interviewers or coordinator or supervisor as needed. The
data will be reviewed on a daily basis by the supervisor for
quality control (so that any issues identified can be quickly
rectified) and uploaded as soon as possible into a central
deidentified database that will be password-protected.
Discrete Choice Experiments Data Analysis and
Interpretation
A hierarchical Bayesian estimation procedure will be used to
assess attributes at the group and individual levels. Hierarchical
regressions simultaneously assess relationships within a given
level and between or across levels. This technique allows for
independent variance to be calculated for both levels
simultaneously. The model will generate preferences for
attributes to assess the most important features and also allow
for the assessment of differences among cohorts (eg,
HIV-positive women vs others). We will conduct policy
simulations reflecting potential changes in the attributes of the
screening facilities and calculate the projected changes in
preference for selecting to undergo cervical cancer screening.
The findings from DCE will be supplemented with information
gained from other qualitative (interviews and focus groups) and
quantitative (patient supplemental survey) data collection to
ensure a comprehensive and context-based interpretation of the
results.
This study has received ethical approval from the Institutional
Review Boards at RTI International and the University of
Zambia’s Biomedical Research Ethics Committee. In addition,
the Zambian Ministry of Health has reviewed and approved this
study.
Availability of Data and Material
We will abide by National Institutes of Health policies and make
the data from this study available to other researchers.
Results
The project was funded in July 2016 and ethical approval was
obtained for the discrete choice experiment in April 2017.
Enrolment is currently ongoing and we plan to complete data
collection by August 2018. First results are expected to be
submitted for publication in 2019.
Discussion
Because willingness to pay for cervical cancer screening has
not been previously assessed, this will be a unique and important
contribution to the literature. Sub-Saharan African countries
have faced challenges in scaling up cervical cancer screening,
and the ability to finance these programs has been one key
barrier. This study, by addressing stakeholder preferences across
key stakeholders as well as HIV-negative and -positive women
and men, will take into account the high HIV prevalence in
Sub-Saharan Africa and prevailing gender attitudes to identify
an optimal package of interventions to reduce cervical cancer
incidence.
Although DCE is a useful approach to elicit tradeoffs and
choices, this experiment may not be able to account for all the
contextual and institutional factors that affect actual behavior,
especially given the complex nature of health care decision
making. We will use the additional qualitative and quantitative
information collected during the DCE implementation and
incorporate background contextual aspects in reaching
conclusions based on the DCE results. Despite the potential
limitations of DCEs, this simulation of women’s decisions (and
men’s support) to undergo screening will lay the foundation for
understanding the stated preferences and willingness to pay to
help design future screening programs. A more systematic
national implementation process that is evidence-based,
data-driven, and resource-based is required for long-term
sustainable cancer control. The establishment of screening
programs in high income countries have resulted in dramatic
decreases in the incidence of cervical cancer [10,11], and with
better implementation of tailored programs in Sub-Saharan, a
similar decline can be achieved.
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